We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 676

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

EU: interim measures awarded against EMA, preventing the Agency from disclosing clinical trial data to third parties

  • Bird & Bird
  • -
  • European Union
  • -
  • May 13 2013

On 25 April 2013 the President of the General Court of the EU Court of Justice made an order granting interim measures in favour of AbbVie and

EFSA reduces TDI for phenol

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 17 2013

The European Food Safety Authority (EFSA) has lowered the tolerable daily intake (TDI) of phenola chemical used to make coatings, adhesives

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

EU-India free trade agreement: pharmaceutical IP protection remains an issue

  • King & Spalding LLP
  • -
  • European Union, India
  • -
  • May 10 2013

The Indian commerce and industry minister recently submitted a letter to the Indian Parliament to update it on the progress in negotiations with the

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

EFSA and ECDC issue report on antimicrobial resistant bacteria

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 17 2013

The European Food Safety Authority (EFSA) and European Centre for Disease Control and Prevention (ECDC) have issued their third joint report "on

Germany seeks stricter nanomaterial reporting rules under REACH

  • Shook Hardy & Bacon LLP
  • -
  • European Union, Germany
  • -
  • May 10 2013

German safety regulators have apparently sought a major nanotechnologyrelated revision of the European Union's Registration, Evaluation

IP challenges for the personalised medicines industry - gene claims (part 1)

  • Barker Brettell LLP
  • -
  • European Union, United Kingdom, USA
  • -
  • May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

UK: Court of Appeal refers questions on parallel imports to CJEU

  • Bird & Bird
  • -
  • European Union, United Kingdom
  • -
  • May 20 2013

The English Court of Appeal has considered the special derogation from the normal free movement of goods rules that formed part of the accession

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy